Endometrial Cancer Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Conditions:   Recurrent Endometrial Carcinoma;   Recurrent Endometrial Clear Cell Adenocarcinoma;   Recurrent Endometrial Endometrioid Adenocarcinoma;   Recurrent Low Grade Endometrial Endometrioid Adenocarcinoma;   Recurrent Low Grade Ovarian Endometrioid Adenocarcinoma;   Recurrent Ovarian C lear Cell Adenocarcinoma;   Recurrent Ovarian Endometrioid Adenocarcinoma;   Recurrent Ovarian High Grade Serous Adenocarcinoma;   Recurrent Platinum-Resistant Ovarian Carcinoma Interventions:   Drug: BET Bromodomain Inhibitor ZEN-3694;   Procedure: Biopsy;   Procedure: Biospecimen Collection;  ...
Source: ClinicalTrials.gov - July 18, 2023 Category: Research Source Type: clinical trials